Itraconazole Pellets 22%
Itraconazole (R51211), invented in 1984, is a triazole antifungal agent prescribed to patients with fungal infections. The drug may be given orally or intravenously.
Starting at
Product Description
|
(2R,4S)-rel-1-(Butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydr
|
| Trade names | Sporanox |
| AHFS/Drugs.com | monograph |
| MedlinePlus | a692049 |
| Pregnancy category |
AU: B3 US: C (Risk not ruled out) |
| Legal status |
AU: S4 (Prescription only) CA: ℞-only UK: POM (Prescription only) US: ℞-only |
| Routes of administration |
Oral and i.v. ,Oral only (UK and US) |
| Bioavailability | 55%, maximal if taken with full meal |
| Protein binding | 99.8% |
| Metabolism | hepatic (CYP3A4) |
| Biological half-life | 21 hours |
| Excretion | Urine, faeces |
| CAS Number | 84625-61-6 |
| ATC code | J02AC02 |
| PubChem | CID: 55283 |
| DrugBank | DB01167 |
| ChemSpider | 49927 |
| UNII | 304NUG5GF4 |
| KEGG | D00350 |
| ChEBI | CHEBI:6076 |
| ChEMBL | CHEMBL22587 |
| Formula | C35H38Cl2N8O4 |
| Molecular mass | 705.64 |
| SMILES[show] | |
| InChI[show] | |
